What we doState-of-the-art biotechnology
centered on antibody engineering

Areas of focus

Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to
human health and well-being worldwide through innovative drug discovery and
global commercialization, driven by state-of-the-art antibody technologies,
in the core therapeutic areas of oncology, nephrology,
central nervous system and immunology.

Cutting-edge biotechnology
centered on antibody
engineering technology

Nephrology Nephrology
Immunology & Allergy Immunology & Allergy
Oncology Oncology
Central Nervous System Central Nervous System

Technology-driven drug discovery

The novel drug discovery of Kyowa Kirin is firmly
supported by the exquisite experience and
technologies in research, development and
manufacture of biologics, and by open
innovation.
This unique style of drug discovery is
what we call technology-driven drug discovery,
focused
on the key technologies below.

Pipeline

Numerous promising pharmaceutical
candidates are emerging from our
development pipelines.
They are the result of our
never-ending efforts in honing the edge of our
state-of-the-art
technologies and deliver
innovation in medical care.

Partnerships

We are open and flexible to strategic collaborations
and partnerships
with pharmaceuticals, biotech,
and academia partners.

ADARE pharmaceuticals™ Allakos genomic medicine™ Alnylam PHARMACEUTICALS AMGEN ardelyx® argenx astellas Leading Light for Life aspen JAPAN AstraZeneca Medlmmune AVEO ONCOLOGY Biogen Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CERECOR CHUGAI Roche A member of the Roche group Daiichi-Sankyo Dexa Medica Expertise for the Promotion of health Eisai first PHARMACEUTICAL FivePrime FOBENI FUJIFILM Genentech IN BUSINESS FOR LIFE gsk HELSINN Building quality cancer care together Hisamitsu Humanigen IDC Theranostics Immunas Pharma inibsa HOSPITAL janssen JB Japan Blood Products Organization Jazz Pharmaceuticals LEO Lonza MEI pharma meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Solasia Syndax synmosa Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion™ TOYOCHEM ultragenyx pharmaceutical Winhealth Pharma WIDATRA Yakult ZUELLIG PHARMA making healthcare more accessible ADARE pharmaceuticals™ Allakos genomic medicine™ Alnylam PHARMACEUTICALS AMGEN ardelyx® argenx astellas Leading Light for Life aspen JAPAN AstraZeneca Medlmmune AVEO ONCOLOGY Biogen Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CERECOR CHUGAI Roche A member of the Roche group Daiichi-Sankyo Dexa Medica Expertise for the Promotion of health Eisai first PHARMACEUTICAL FivePrime FOBENI FUJIFILM Genentech IN BUSINESS FOR LIFE gsk HELSINN Building quality cancer care together Hisamitsu Humanigen IDC Theranostics Immunas Pharma inibsa HOSPITAL janssen JB Japan Blood Products Organization Jazz Pharmaceuticals LEO Lonza MEI pharma meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Solasia Syndax synmosa Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion™ TOYOCHEM ultragenyx pharmaceutical Winhealth Pharma WIDATRA Yakult ZUELLIG PHARMA making healthcare more accessible